Protein Dx Firm Courtagen Raises $8M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Courtagen Life Sciences has raised $8 million in equity funding, the company disclosed in a regulatory filing on Friday.

The document filed with the US Securities Exchange Commission did not reveal how the funds will be used or who the participants in the round were but said that there were 67 investors.

A company spokesperson did not respond to a request for comment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.